Generated by AI
Innate Pharma S.A. Sponsored ADR is a biotechnology company focused on developing immunotherapies for cancer patients. The company uses antibody engineering and natural killer cell-based approaches to build treatments aimed at harnessing the innate immune system, with a pipeline that includes programs for hematologic cancers and solid tumors. Its current work spans clinical-stage drug development, research collaborations, and licensing arrangements with major pharmaceutical partners, reflecting a business model centered on advancing proprietary candidates through development while leveraging partnerships to broaden its therapeutic reach. Innate Pharma operates primarily in the oncology and immunotherapy segments of the healthcare market, serving as a specialized developer of next-generation antibody-based medicines. Headquartered in Marseille, France, it maintains an international presence through research and collaboration activities that support its role in modern cancer drug development.
Website117, Avenue de Luminy
Marseille, 13009
France
The latest articles about IPHA.
Summary of Sep 17's posts. Generated by AI.
Summary of Nov 10's posts. Generated by AI.
Summary of Nov 10's posts. Generated by AI.
Summary of Sep 17's posts. Generated by AI.
Investors talking about IPHA also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.